Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TORCH-ICU: Tracing Of Real-time glu13Cose Metabolism in Human Immune Cells
NCT07811180Not yet recruiting
- Sponsor
- Vanderbilt University Medical Center
- Start
- Nov 2026
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Vanderbilt University Medical Center. Primary endpoint: 13C6-Glucose Uptake and Metabolism in Immune Cells at 4 hours. Planned start Nov 2026; status: not yet recruiting.
Beyond the preview
Go deeper on NCT07811180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07811180.